The goal of molecular medicine is to understand the dynamics of health and disease on the cellular and molecular level in order to stem pathological changes at an early stage.
Together with partners Siemens Healthcare has been researching and developing applications in this field for many years. We’re leading the field of hybrid-imaging such as PET-CT and SPECT-CT as well as are highly engaged in developing and producing biomarkers. And, we’ve broadened our diagnostics expertise through acquisitions. As a result, we are now a truly full-range company with imaging diagnostics, laboratory diagnostics, and clinical information technology all under one roof.